Scientists uncover how brain shrinkage across multiple regions accelerates memory decline in healthy ageing adults.
US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...
A massive international brain study has revealed that memory decline with age isn’t driven by a single brain region or gene, ...
Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...
Analysing thousands of MRI scans and memory tests from healthy adults, researchers found that memory loss accelerates as brain tissue shrinkage increases, especially later in life. While the ...
Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...
Kaiser Permanente (Kaiser) has agreed to pay $556 million to resolve False Claims Act litigation alleging improper Medicare Advantage risk-adjustment practices, according to the U.S. Department of ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no ...
Repeated exercise, or wasting, can change the way key genes work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback